Insulet Corp. (PODD)

156.84 +0.25 (+0.16%) USD  |  NASDAQ  |  May 21, 16:00
156.84 0.00 (0.00%) After-Hours: 16:47
More

Insulet Research and Development Expense (TTM) : 331.20M for March 31, 2026

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for PODD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Boston Scientific Corp. 2.125B
Abbott Laboratories 2.954B
Intuitive Surgical, Inc. 1.357B
Stryker Corp. 1.578B
Tandem Diabetes Care, Inc. 188.10M